Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Booali Daroo is an Iranian pharmaceutical company dedicated to the development and manufacture of herbal medicines based on Traditional Persian Medicine (TPM). By combining ancient medical insights with modern pharmacological standards, the company produces a wide range of standardized natural products for various therapeutic applications. Their portfolio includes treatments for neurological disorders, gastrointestinal ailments, and metabolic conditions, all manufactured under strict Good Manufacturing Practice (GMP) guidelines. The company's flagship product, Recleptic, is a clinically studied herbal formulation used as an adjunctive treatment for epilepsy. Booali Daroo aims to provide safe and effective natural alternatives to synthetic drugs, leveraging the rich botanical heritage of the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Booali Daroo.